Effect of plant sterol margarines on serum cholesterol in everyday practice

ISRCTN ISRCTN61150880
DOI https://doi.org/10.1186/ISRCTN61150880
Secondary identifying numbers 4/3/03
Submission date
19/02/2009
Registration date
31/03/2009
Last edited
13/10/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Michael Moore
Scientific

Primary Medical Care
Aldermoor Close
Southampton
SO16 1ST
United Kingdom

Study information

Study designOpen randomised crossover trial
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleAn open randomised trial of the effect of plant sterol margarines on serum cholesterol in everyday practice
Study acronymSPREADS
Study objectives1. To estimate the effect of advice to use a plant sterol margarine in a free living population when compared to a polyunsaturated margarine among those with hypercholesterolaemia.
2. To estimate whether sterols reduce beta-carotene levels and if this can be counteracted by an increase in fruit and vegetable consumption.
Ethics approval(s)1. South Wiltshire Ethics Committee, approved in 2002, ref: SA231/2002
2. Southampton City Ethics Committee, approved in 2002, ref: 328/02/w
Health condition(s) or problem(s) studiedHypercholesterolaemia in adults
InterventionPolyunsaturated margarine or sterol enriched margarine taken for 6 weeks with a crossover design (no washout period).
Total duration of interventions and follow-up: 12 weeks
Intervention typeSupplement
Primary outcome measureSerum cholesterol and beta-carotene assessed at baseline, 6 and 12 weeks
Secondary outcome measuresHigh-density lipoprotein (HDL) cholesterol, total cholesterol (TC)/HDL ratio, assessed at baseline, 6 and 12 weeks
Overall study start date01/09/2003
Completion date31/03/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants232
Key inclusion criteriaAdult (both males and females) over 18 with cholesterol >6 mmol
Key exclusion criteriaThose considered unsuitable by their GP e.g., cancer, acute or chronic psychotic disorder or dementia
Date of first enrolment01/09/2003
Date of final enrolment31/03/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Primary Medical Care
Southampton
SO16 1ST
United Kingdom

Sponsor information

University of Southampton (UK)
University/education

University Road
Southampton
so17 1bj
England
United Kingdom

Website http://www.soton.ac.uk/
ROR logo "ROR" https://ror.org/01ryk1543

Funders

Funder type

University/education

Royal College of General Practitioners (RCGP) - Scientific Foundation Board (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

13/10/2017: No publications found, verifying study status with principal investigator.